The estimated Net Worth of Isaac Samuel Kohane is at least $1.42 Million dollars as of 18 June 2021. Isaac Kohane owns over 9,165 units of Innovator ETFs Trust stock worth over $993,408 and over the last 6 years he sold INOV stock worth over $0. In addition, he makes $425,000 as Independent Director at Innovator ETFs Trust.
Sign up
Isaac Kohane INOV stock SEC Form 4 insiders trading
Isaac has made over 3 trades of the Innovator ETFs Trust stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 9,165 units of INOV stock worth $266,793 on 18 June 2021.
The largest trade he's ever made was exercising 12,654 units of Innovator ETFs Trust stock on 6 June 2020 worth over $368,358. On average, Isaac trades about 4,266 units every 61 days since 2019. As of 18 June 2021 he still owns at least 34,126 units of Innovator ETFs Trust stock.
You can see the complete history of Isaac Kohane stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Isaac Kohane biography
Dr. Isaac Samuel Kohane M.D., Ph.D., is Independent Director of the company. Dr. Kohane has served as a director of Inovalon since January 2019. Dr. Kohane is the inaugural Chair of the Department of Biomedical Informatics and the Marion V. Nelson Professor of Biomedical Informatics at Harvard Medical School, a position he has held since 2015. He served as co-author of the Institute of Medicine Report on Precision Medicine that has been the template for national efforts. He is an industry leader in the development and application of computational techniques to address disease at multiple scales, from whole healthcare systems as “living laboratories” to functional genomics. Dr. Kohane leads the Informatics for Integrating Biology and the Bedside (i2b2) project, a National Institute of Health (NIH)-funded National Center for Biomedical Computing (NCBC) initiative based in Boston, which is currently deployed internationally to more than 120 major academic health centers. Dr. Kohane also currently leads several NIH-funded projects including a Center of Excellence in Big Data to Knowledge. Dr. Kohane received his International Baccalaureate from the International School of Geneva. He received a Bachelor of Science in Biology with a concentration in computer science with honors from Brown University, undertook pre-clinical studies at Boston University School of Medicine and undertook his doctoral work at Boston University in the Clinical Decision Making Group of Massachusetts Institute of Technology lab for Computer Science. He received his medical degree and doctorate from Boston University. Dr. Kohane performed his postdoctoral training at Children’s Hospital in Boston, MA. He holds or has held academic appointments at Harvard Medical School, Children’s Hospital Boston, the Dana-Farber Cancer Institute in Boston, and the Brigham and Women’s Hospital in Boston.
What is the salary of Isaac Kohane?
As the Independent Director of Innovator ETFs Trust, the total compensation of Isaac Kohane at Innovator ETFs Trust is $425,000. There are 4 executives at Innovator ETFs Trust getting paid more, with Peter De Bock having the highest compensation of $2,866,730.
How old is Isaac Kohane?
Isaac Kohane is 59, he's been the Independent Director of Innovator ETFs Trust since 2019. There are 7 older and 5 younger executives at Innovator ETFs Trust. The oldest executive at Innovator ETFs Trust is Denise Fletcher, 71, who is the Independent Director.
What's Isaac Kohane's mailing address?
Isaac's mailing address filed with the SEC is 4321, Collington Road, Essington, Bowie, Prince George's County, Maryland, 20716, United States.
Insiders trading at Innovator ETFs Trust
Over the last 10 years, insiders at Innovator ETFs Trust have traded over $17,222,256 worth of Innovator ETFs Trust stock and bought 1,096,675 units worth $14,934,745 . The most active insiders traders include Keith R Dunleavy, Christopher E Greiner und William D Green. On average, Innovator ETFs Trust executives and independent directors trade stock every 36 days with the average trade being worth of $987,207. The most recent stock trade was executed by William J Jr Teuber on 18 June 2021, trading 9,165 units of INOV stock currently worth $266,793.
What does Innovator ETFs Trust's logo look like?
Complete history of Isaac Kohane stock trades at Innovator ETFs Trust
Innovator ETFs Trust executives and stock owners
Innovator ETFs Trust executives and other stock owners filed with the SEC include:
-
Peter De Bock,
Chief Administrative Officer -
Jonathan Boldt,
Chief Financial Officer -
Jason Capitel,
Chief Operating Officer -
Robert Wychulis,
President -
Isaac Kohane,
Independent Director -
William Teuber,
Independent Director -
Lee Roberts,
Independent Director -
William Green,
Independent Director -
Denise Fletcher,
Independent Director -
Mark Pulido,
Non-Independent Director -
Dr. Keith R. Dunleavy,
Founder, Chairman & CEO -
Keith Dunleavy,
Chairman of the Board, Chief Executive Officer -
Andre Hoffmann,
Independent Director -
Dr. Paige C. Kilian M.D.,
Chief Medical Officer -
Ingrid E. Olsen,
Chief People Officer -
Kim E. Collins,
Sr. VP of Corp. Marketing & Communications -
Beverly Allen,
Gen. Counsel, Chief Compliance & Privacy Officer -
Hulus Alpay,
VP of Investor Relations -
Geoff Charron,
Chief Technology Officer -
June Duchesne,
Chief Legal Officer -
Shauna L Vernal,
Chief Legal Officer -
Joseph R Rostock,
Chief Technology Officer -
Daniel L Rizzo,
Chief Innovation Officer -
Thomas R Kloster,
Chief Financial Officer -
Christopher E Greiner,
Chief Product Officer & COO -
John Michael Burgin,
Chief Product Officer -
Eron Kelly,
President